SB 9872026
bill
2026 Regular Session · Senate bill
SB 987
Corporate Income Tax - Addition Modification - Direct-to-Consumer Pharmaceutical Advertising
In committee Last action March 5, 2026: Hearing 3/11 at 1:00 p.m.
Official bill page and text: mgaleg.maryland.gov
Sponsors 1
- Prime sponsor
- Lewis Young
Status
In committee as of March 5, 2026. The 2026 session has adjourned; the 2027 session convenes January 13, 2027.
Referred to: Senate Rules (from the official referral record)
Roll-call votes 0
No roll-call votes recorded for this measure.
Timeline 3
| Date | Chamber | Action |
|---|---|---|
| March 5, 2026 | Senate | Hearing 3/11 at 1:00 p.m. |
| March 4, 2026 | Senate | Rereferred to Budget and Taxation |
| February 15, 2026 | Senate | First Reading Senate Rules |
Data: Open States (API v3; public data, attribution appreciated). Official record: mgaleg.maryland.gov. Bill pages link to the official text, not copied.